| 英文别名： |
1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide;5-ISOBENZOFURANCARBONITRILE, 1,3-DIHYDRO-1-(3-(DIMETHYLAMINO)PROPYL)-1-(4-FLUOROPHENYL)-;CITALOPRAM HBR;(+/-)-CITALOPRAM HYDROBROMIDE;5-isobenzofurancarbonitrile,1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3;Citalopram Hydrobromide Tablets;1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrobromide;Citalopram (hydrobromide);Citalopram hydrobromide solution;Citalopram, Hydrobromide Salt;(¡À)-Citalopram hydrobromide;(±)-Citalopram hydrobromide;Citalopram;Lu 10-171;Lu 10-171B;1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile hydrobromide;Citalopram hydrobromide;1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide;Cipramil;Celexa;Seropram;Elopram;Bonitrile HBr;Nitalapram HBr;Prepram HBr;Citalopram hydrobromide [USAN];CPD000326936;Cit;Citalopram HBr;NSC758684;NS00088112;1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile monohydrobromide;MFCD02101306;CITALOPRAM HYDROBROMIDE [USP-RS];I1E9D14F36;Tox21_500258;1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrobromide;Citalopram hydrobromide, >=98% (HPLC);1-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile monohydrobromide;CITALOPRAM HYDROBROMIDE (USP IMPURITY);C20H22BrFN2O;SR-01000003129-2;5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, monohydrobromide;CITALOPRAM HYDROBROMIDE [EP MONOGRAPH];D00822;Citalopram for system suitability, European Pharmacopoeia (EP) Reference Standard;Citalopram hydrobromide, United States Pharmacopeia (USP) Reference Standard;SMR000326936;LU-10-171-B;Citalopram.HBr;Prisdal;CCG-101022;BC164316;Citalopram Hydrobromide, Pharmaceutical Secondary Standard; Certified Reference Material;Citalopram.HBr, 1mg/ml in Methanol;59729-32-7;CCG-213271;NCGC00093717-02;UNII-I1E9D14F36;MLS000860078;MLS000758293;KS-1043;ZD-211;A832439;Q-200865;Lu 10-171 HBr;CS-4735;1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromide;CITALOPRAM, HYDROBROMIDE SALT;WIHMBLDNRMIGDW-UHFFFAOYSA-N;AC-1595;Pharmakon1600-01504172;HY-B1287;ZD 211;Citalopram hydrobromide [USAN:USP];NCGC00260943-01;FT-0600173;CITALOPRAM HYDROBROMIDE (USP MONOGRAPH);DTXCID60819993;Citalopram (as hydrobromide);SR-01000003129;LP00258;Lupram;Citalopram hydrogen bromide- Bio-X;NSC 758684;Lu 10-171-B;MLS001401376;CITALOPRAM HYDROBROMIDE [HSDB];DTXSID40872344;AKOS005145738;CITALOPRAM HYDROBROMIDE [ORANGE BOOK];NCGC00093717-03;CITALOPRAM HYDROBROMIDE [USP IMPURITY];MLS002222294;1-(3-Dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile hydrobromide;CITALOPRAM HYDROBROMIDE (MART.);1-[3-(dimethylamino... |
沪公网安备31011402010658号 
